Search Results
178 items found for "autoimmune disease"
- GPCRs are not simple on-off switches: deep dive into GPCR-ligand interactions
free fatty acid receptors (FFARs), now regarded as targets for therapeutic intervention for metabolic diseases such as liver disease, obesity and diabetes (Secor et al. 2021; Wold and Zhou 2018).
- C5aR2 receptor: The genomic twin of the flamboyant C5aR1
the C5aR1, which has received enormous attention for its role in both acute and chronic inflammatory diseases
- Combined docking and machine learning identify key molecular determinants of ligand pharmacological
September 2022 "G protein‐coupled receptors (GPCRs) are valuable therapeutic targets for many diseases
- PAR-Induced Harnessing of EZH2 to β-Catenin: Implications for Colorectal Cancer
September 2022 "G-protein-coupled receptors (GPCRs) are involved in a wide array of physiological and disease
- Structure-Based Discovery of Negative Allosteric Modulators of the Metabotropic Glutamate Receptor 5
The mGlu5 receptor is a promising target for the treatment of psychiatric and neurodegenerative diseases
- Sosei Heptares Enters Antibody Discovery Agreement with Twist Bioscience to Discover and Develop ...
Sosei Heptares’ world-leading StaR® (stabilized receptor) platform to generate novel antibody leads to disease-relevant
- 📰 GPCR Weekly News, February 20 to 26, 2023
Receptors: Insights into Potential Therapeutic Opportunities for COVID-19, Heart Failure, and Alzheimer's Disease Reviews, GPCRs, and more Cell-trafficking impairment in disease-associated LPA6 missense mutants and
- A Chemical Biology Toolbox Targeting the Intracellular Binding Site of CCR9: Fluorescent Ligands ...
receptor type 9 (CCR9) antagonist and previous phase III clinical candidate for the treatment of Crohn's disease
- Actions of Parathyroid Hormone Ligand Analogues in Humanized PTH1R Knockin Mice
) ligands and analogues for their pharmacologic activities and potential therapeutic utility toward diseases
- Adrenal G Protein-Coupled Receptors and the Failing Heart: A Long-distance, Yet Intimate Affair
chronic clinical syndrome characterized by the reduction in cardiac function and still remains the disease
- Cell-Type-Specific Effects of the Ovarian Cancer G-Protein Coupled Receptor (OGR1) on Inflammation..
Potential Implications for Idiopathic Pulmonary Fibrosis "Idiopathic pulmonary fibrosis (IPF) is a disease
- Twist Bioscience Launches Revelar Biotherapeutics to Develop and Commercialize Novel COVID-19...
to Develop and Commercialize Novel COVID-19 and Other Antibody Therapeutics for Difficult to Treat Diseases
- Crinetics Pharmaceuticals announced the formation of an independently operated new company...
focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases
- 📰 GPCR Weekly News, March 25 to March 31, 2024
using next-generation GRABNE sensors Reviews, GPCRs, and more Advances in GPCRs: Structure, Mechanisms, Disease Therapeutics Secures VLAIO Grant Supporting Drug Discovery & Development In Endocrine And Metabolic Diseases
- GPR3 expression in retinal ganglion cells contributes to neuron survival and accelerates axonal...
optic nerve crush in mice "Glaucoma is an optic neuropathy and is currently one of the most common diseases
- Canonical chemokine receptors as scavenging “decoys”
However, an imbalance in the chemokine system can also contribute to various diseases, such as inflammatory
- TLR4 biased small molecule modulators
Moreover, the dysregulation of TLR4 contributes to numerous diseases, which highlights the importance
- High GPER expression in triple-negative breast cancer is linked to pro-metastatic pathways and...
patient outcomes "Triple-negative breast cancer (TNBC) is a particularly aggressive and heterogeneous disease
- Opposite Effects of Src Family Kinases on YAP and ERK Activation in Pancreatic Cancer Cells...
Cells: Implications for Targeted Therapy "Pancreatic ductal adenocarcinoma (PDAC) remains an aggressive disease
- Targeting Intracellular Allosteric Sites in GPCRs
free fatty acid receptors (FFARs), now regarded as targets for therapeutic intervention for metabolic diseases such as liver disease, obesity and diabetes (Wold and Zhou 2018).
- Unlocking the Therapeutic Potential of Previously Undruggable GPCRs
While these small protein GPCRs are valuable drug targets linked to serious diseases, many remain undrugged antagonist analogs have demonstrated powerful efficacies across a range of animal models spanning different disease Since many inflammatory diseases are driven by inappropriate recruitment of monocytes into tissues, CCR2 diversified portfolio of GPCR-targeted drug candidates for the treatment of cancer and other serious diseases Journal of Infectious Diseases, 199, 1525-1527. https://doi.org/10.1086/598685 · Demonstration
- A Model for the Signal Initiation Complex Between Arrestin-3 and the Src Family Kinase Fgr
suggests that Fgr interacts with arrestin-3 at multiple sites and is consistent with the locations of disease-associated
- β-arrestin1 promotes tauopathy by transducing GPCR signaling, disrupting microtubules and autophagy
G protein-coupled receptors (GPCRs) have been shown to play integral roles in Alzheimer's disease pathogenesis
- 📰 GPCR Weekly News, March 27 to April 4, 2023
First complete genome sequence of lumpy skin disease virus directly from a clinical sample in South India Therapeutics Enters into Collaboration Agreement with Daiichi Sankyo to Discover Novel Medicines for CNS Diseases
- 📰 GPCR Weekly News
GPCR Activation and Signaling Targeting GRK2 and GRK5 for treating chronic degenerative diseases: Advances
- Rescue of Cell Surface Expression and Signaling of Mutant Follicle-Stimulating Hormone Receptors
Mutations in G protein-coupled receptors (GPCRs) underlie numerous diseases.
- Odorant G protein-coupled receptors as potential therapeutic targets for adult diffuse gliomas ...
distinct from odor perception, and may contribute to the pathogenesis of disorders including brain diseases
- Dynamic GPCR activation revealed through time-resolved Cryo-EM
With this high-resolution, dynamic view of GPCR activation, scientists can better tackle diseases by